ANI Pharmaceuticals ANIP
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 91.60 | 103.27 | 1.10 | 36,240 | 27 | |
| 2025Q2 | 65.25 | 88.87 | 0.36 | 13,892 | 9 | |
| 2025Q1 | 66.95 | 99.25 | 0.69 | 26,194 | 16 | |
| 2024Q4 | 55.28 | 76.06 | -0.55 | -4,378 | -10 | |
| 2024Q3 | 59.66 | 67.23 | 49.42 | -1.19 | -20,519 | -24 |
| 2024Q2 | 63.68 | 101.73 | 39.37 | -0.12 | 5,169 | -2 |
| 2024Q1 | 69.13 | 79.26 | 84.95 | 0.82 | 20,312 | 18 |
| 2023Q4 | 55.14 | 100.49 | 95.16 | 0.02 | 6,726 | 1 |
| 2023Q3 | 58.06 | 100.22 | 0.47 | 17,948 | 10 | |
| 2023Q2 | 53.83 | 100.43 | 0.30 | 12,402 | 6 | |
| 2023Q1 | 39.72 | 100.34 | 0.06 | 9,895 | 1 | |
| 2022Q4 | 40.23 | 102.36 | -0.29 | 1,820 | -4 | |
| 2022Q3 | 32.14 | 100.75 | -0.55 | -4,995 | -9 | |
| 2022Q2 | 29.67 | 106.29 | -0.94 | -12,913 | -15 | |
| 2022Q1 | 28.11 | 99.54 | -1.27 | -19,195 | -20 | |
| 2021Q4 | 46.08 | 89.82 | -1.87 | -23,723 | -24 | |
| 2021Q3 | 32.82 | 76.88 | -0.37 | -3,562 | -4 | |
| 2021Q2 | 35.05 | 99.57 | -1.17 | -15,553 | -14 | |
| 2021Q1 | 36.14 | 120.36 | 0.01 | 3,045 | 0 | |
| 2020Q4 | 29.04 | 192.44 | -0.30 | 331 | -4 |